School of Medicine


Showing 1-10 of 17 Results

  • Rachel Hagey Saluti

    Rachel Hagey Saluti

    Staff Research Scientist, Medicine - Med/Gastroenterology and Hepatology

    BioMy primary research focus is in translational molecular virology and drug discovery/development. My work aims to uncover and characterize novel virus targets for the rational design of new classes of antiviral therapeutics.

  • Adrish Sen

    Adrish Sen

    Affiliate, Medicine - Med/Gastroenterology and Hepatology

    BioMy research focuses on Rotavirus (RV) - the causative agent of acute infantile diarrhea, that is responsible for more than 200,000 deaths annually. My earlier work explored RV molecular epidemiology and virion assembly mechanisms. This led to the identification of novel group B rotaviruses, which cause adult diarrhea in humans and exhibit pandemic potential. I subsequently characterized molecular mechanisms by which rotaviruses assemble in infected cells - specifically how a viral non-structural protein, NSP5, forms higher-order assembly scaffolds by a calcium-triggered reversible molecular switch.
    Since moving to Stanford University, my research in Dr. Harry Greenberg’s laboratory has focused on understanding the role that innate immunity plays in determining rotavirus species barriers, pathogenicity, and shaping the overall immune response to natural and vaccine-related RV infections. Our work defined the pathways leading to RV recognition by the host interferon response and uncovered viral strategies to regulate this process. Single-cell studies have revealed that RV degrades all three major IFN type receptors in infected cells, and remarkably, also confers pleiotropic IFN resistance to RV-bystander cells (which express normal levels of IFN receptors). These viral regulatory mechanisms possibly underlie the unexpected ability of RV infection to prevent lethal endotoxemia, which we reported recently. I have a strong interest in dissecting host antiviral responses to pathogenic and attenuated viruses at the population and single-cell levels using microfluidics qRT-PCR, multi-color cytometry, and novel mass cytometry techniques. In other ongoing research, I am examining differences in cell type-specific innate responses to pathogenic and attenuated influenza viruses in the human nasal mucosa (primarily using clinical and volunteer nasal swab specimens).

  • Atulkumar T. Shah, MD

    Atulkumar T. Shah, MD

    Clinical Instructor, Medicine - Gastroenterology & Hepatology

    BioDr. Shah is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care’s Digestive Health program. He is a clinical associate professor of medicine in the division of Gastroenterology and Hepatology at Stanford University School of Medicine.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    After more than two decades of practice, Dr. Shah added training in liver transplant to expand his knowledge of liver disease and offer his patients a “one-stop” resource for truly comprehensive care.

    Dr. Shah is a member of the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy, and American Association for the Study of Liver Disease.

    Among Dr. Shah’s current research interests is the development of an algorithm assessing the impact of gastrointestinal disease management on readmission rates.

    Dr. Shah brings a personalized approach to working with patients and to teaching the next generation of physician scientists the classic skills of careful listening and patient examination. Throughout his career, he has emphasized the fundamental importance of balancing scientific expertise with empathy and compassion.

    As a volunteer with the non-profit organization Health Volunteers Overseas, Dr. Shah travels around the world to train physicians about liver disease management and treatment. He is director of the HVO site in Bangalore, India.

  • Edward Sheen

    Edward Sheen

    Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology

    BioEdward Sheen is Chief Medical Officer, Market Development and Solution Design at Lumeris. Lumeris is a leading value-based care delivery operator aligning and transforming health systems and payers across the country to improve population health, reduce costs of care, enhance patient experience, and strengthen care provider engagement. Through its operations, technology, change management, and strategic advisory solutions, Lumeris establishes population health services organizations and collaborative, aligned health plans to deliver accountable person-centered care.

    His experience has bridged the public, private, non-profit, and academic sectors and includes work with Stanford University, the White House, U.S. Department of Defense, U.S. Department of Health and Human Services, California State Assembly, Kaiser Family Foundation, Blue Shield of California, California/American Medical Associations, and Genzyme, as well as advising early stage healthcare companies. In 2014 he was one of 15 Americans appointed by President Barack Obama a nonpartisan White House Fellow, and selected to be the White House Fellow to the Secretary of Defense. In this capacity, he served as a Special Assistant to the Secretary and Defense Department senior health policy advisor, and was a recipient of the Office of the Secretary of Defense Medal for Exceptional Public Service. Dr. Sheen is also Adjunct Professor of Medicine and a Term Member of the Council on Foreign Relations. He is dedicated to achieving more accessible, innovative, patient-centered, and high-performing health care and bringing together teams and communities to care for vulnerable populations. He also has a long commitment to mentoring, medical education, and supporting the leadership development of future change agents.

    Dr. Sheen completed his Internal Medicine and Gastroenterology training at Stanford, received his MD from the University of California, San Francisco and earned his MBA and MPH degrees through scholarships from Stanford Graduate School of Business and Harvard School of Public Health, where he was also a Harvard Kennedy School Center for Public Leadership Zuckerman Fellow. He graduated magna cum laude from Brown University with a B.A. in Public Policy and induction to Phi Beta Kappa.